Cupid Ltd Shares Soar 10% on Strategic Middle East Investment
Cupid Ltd, a personal care products manufacturer, has seen its shares increase by 10% over three days, reaching an all-time high of Rs 147.00 on the BSE. This surge follows the company's investment in GII Healthcare Investment Ltd, marking its entry into the Middle East market, particularly Saudi Arabia. Cupid Ltd recently expanded its production capacity in Maharashtra and exports to over 110 countries. The company's Chairman and Managing Director, Mr. Aditya Kumar Halwasiya, has been recognized in the Avendus Wealth – Hurun India U30 List 2025.
15Jul 25
Cupid Limited Expands into Middle East Healthcare Market with Strategic Investment
Cupid Limited, an Indian healthcare and hygiene products manufacturer, has made a strategic investment in GII Healthcare Investment Limited, marking its entry into the Middle Eastern healthcare market. GII Healthcare, managed by Gulf Islamic Investments, holds a significant minority stake in a leading Saudi Arabian healthcare provider. This move aligns with Cupid's long-term vision to diversify and expand into high-growth global markets. The investment is expected to create synergies between Cupid's product portfolio and the Gulf Cooperation Council (GCC) healthcare market, potentially opening new distribution channels for the company's products including contraceptives, personal care gels, and diagnostic kits.
21May 25
CUPID's Q4 Earnings: Revenue and Profitability Decline Amid Market Challenges
CUPID Limited, a leading contraceptive industry player, released Q4 financial results showing a substantial decline in key metrics. Revenue decreased by 10.17% year-over-year to ₹565.00 million. EBITDA fell by 56.31% to ₹135.00 million, with the EBITDA margin dropping to 23.81%. Net profit declined by 51.05% to ₹116.00 million compared to the previous year. However, there was a slight 4.5% sequential growth in net profit from the previous quarter.
26Feb 25
Cupid Limited Secures ₹420 Crore Order from Tanzania's Medical Stores Department
Cupid Limited has received a substantial order for male condoms from Tanzania's Medical Stores Department, valued at approximately ₹420 crore ($5.1 million USD). The order is to be executed between May and July 2025. This development marks a significant expansion into the African market for Cupid, a leading manufacturer of condoms and healthcare products. The company's management views this as a testament to their recent efforts in relationship building and sees it as a step towards sustainable growth in both B2B and B2C sectors.